The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Onychomycosis: a review
Abstract
Onychomycosis is a fungal infection of the nail, causing discoloration and thickening of the affected nail plate, and is the most common nail infection worldwide. Onychomycosis was initially thought to be predominantly caused by dermatophytes; however, new research has revealed that mixed infections and those caused by non‐dermatophyte moulds (NDMs) are more prevalent than previously thought, especially in warmer climates. Microscopy and fungal culture are the gold standard techniques for onychomycosis diagnosis, but high false‐negative rates have pushed for more accurate methods, such as histology and PCR. As NDMs are skin and laboratory contaminants, their presence as an infectious agent requires multiple confirmations and repeated sampling. There are several treatment options available, including oral antifungals, topicals and devices. Oral antifungals have higher cure rates and shorter treatment periods than topical treatments, but have adverse side effects such as hepatotoxicity and drug interactions. Terbinafine, itraconazole and fluconazole are most commonly used, with new oral antifungals such as fosravuconazole being evaluated. Topical treatments, such as efinaconazole, tavaborole, ciclopirox and amorolfine have less serious side effects, but also have generally lower cure rates and much longer treatment regimens. New topical formulations are being investigated as faster‐acting alternatives to the currently available topical treatments. Devices such as lasers have shown promise in improving the cosmetic appearance of the nail, but due to a high variation of study methods and definitions of cure, their effectiveness for onychomycosis has yet to be sufficiently proven. Recurrence rates for onychomycosis are high; once infected, patients should seek medical treatment as soon as possible and sanitize their shoes and socks. Prophylactic application of topicals and avoiding walking barefoot in public places may help prevent recurrence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Melt extrusion: from process to drug delivery technology
Breitenbach, J. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00061-9 · Cited by 742
Onychomycosis: Pathogenesis, Diagnosis, and Management
Elewski, B. E. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.415 · Cited by 585
Ramage, G., Rajendran, R., Sherry, L., & Williams, C. (2012) · International Journal of Microbiology · doi:10.1155/2012/528521 · Cited by 583
Ghannoum, M. A., Hajjeh, R. A., Scher, R., Konnikov, N., Gupta, A. K., Summerbell, R., Sullivan, S., Daniel, R., Krusinski, P., Fleckman, P., et al. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.107754 · Cited by 534
Self-citationOur Current Understanding of Fungal Biofilms
Ramage, G., Mowat, E., Jones, B., Williams, C., & Lopez-Ribot, J. (2009) · Critical Reviews in Microbiology · doi:10.3109/10408410903241436 · Cited by 483
Terbinafine: Mode of action and properties of the squalene epoxidase inhibition
RYDER, N. S. (1992) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1992.tb00001.x · Cited by 435
Pharmacokinetics and Tissue Penetration of Fluconazole in Humans
Brammer, K. W., Farrow, P. R., & Faulkner, J. K. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.supplement_3.s318 · Cited by 429
Gupta, A. K., Jain, H. C., Lynde, C. W., MacDonald, P., Cooper, E. A., & Summerbell, R. C. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.104794 · Cited by 380
Self-citationAntifungal agents: An overview. Part I
Gupta, A. K., Sauder, D. N., & Shear, N. H. (1994) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(08)81495-8 · Cited by 369
Self-citationGupta, Konnikov, Macdonald, Rich, Rodger, Edmonds, Mcmanus, & Summerbell (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.02464.x · Cited by 340
Balfour, J. A., & Faulds, D. (1992) · Drugs · doi:10.2165/00003495-199243020-00010 · Cited by 280
British Association of Dermatologists' guidelines for the management of onychomycosis 2014
Ameen, M., Lear, J. T., Madan, V., Mohd Mustapa, M. F., Richardson, M., Hughes, J. R., Sahota, A., Griffiths, M., McDonagh, A. J., Punjabi, S., et al. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13358 · Cited by 243
Lipner, S. R., & Scher, R. K. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.05.1260 · Cited by 243
Elewski, B. E. (1997) · Archives of Dermatology · doi:10.1001/archderm.1997.03890450124022 · Cited by 232
Eenglish, M. P. (1976) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1976.tb05171.x · Cited by 232
Elewski, B. E., Rich, P., Pollak, R., Pariser, D. M., Watanabe, S., Senda, H., Ieda, C., Smith, K., Pillai, R., Ramakrishna, T., et al. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.10.013 · Cited by 231
Onychomycosis in clinical practice: factors contributing to recurrence
Scher, R. K., & Baran, R. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.149.s65.5.x · Cited by 224
Sigurgeirsson, B., Ólafsson, J. H., Steinsson, J. Þ., Paul, C., Billstein, S., & Evans, E. G. V. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.3.353 · Cited by 212
Gupta, A. K., Jain, H. C., Lynde, C. W., Watteel, G. N., & Summerbell, R. C. (1997) · International Journal of Dermatology · doi:10.1046/j.1365-4362.1997.00349.x · Cited by 205
Self-citationElewski, B. E. (1997) · Archives of Dermatology · doi:10.1001/archderm.133.9.1172 · Cited by 202
Fungicidal Drugs Induce a Common Oxidative-Damage Cellular Death Pathway
Belenky, P., Camacho, D., & Collins, J. J. (2013) · Cell Reports · doi:10.1016/j.celrep.2012.12.021 · Cited by 199
Welsh, O., Vera-Cabrera, L., & Welsh, E. (2010) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2009.12.006 · Cited by 179
The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects
Van Peer, A., Woestenborghs, R., Heykants, J., Gasparini, R., & Gauwenbergh, G. (1989) · European Journal of Clinical Pharmacology · doi:10.1007/bf00558308 · Cited by 176
Faergemann, J., Zehender, H., Denouël, J., & Millerioux, L. (1993) · Acta Dermato-Venereologica · doi:10.2340/000155557300304 · Cited by 172
Doncker, P. D., Decroix, J., Piérard, G. E., Roelant, D., Woestenborghs, R., Jacqmin, P., Odds, F., Heremans, A., Dockx, P., & Roseeuw, D. (1996) · Archives of Dermatology · doi:10.1001/archderm.132.1.34 · Cited by 172
Increased Gastric pH and the Bioavailability of Fluconazole and Ketoconazole
Blum, R. A., D'Andrea, D. T., Florentino, B. M., Wilton, J. H., Hilligoss, D. M., Gardner, M. J., Henry, E. B., Goldstein, H., & Schentag, J. J. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-755 · Cited by 167
Epidemiology and prevalence of onychomycosis in HIV‐positive individuals
Gupta, A. K., Taborda, P., Taborda, V., Gilmour, J., Rachlis, A., Salit, I., Gupta, M. A., MacDonald, P., Cooper, E. A., & Summerbell, R. C. (2000) · International Journal of Dermatology · doi:10.1046/j.1365-4362.2000.00012.x · Cited by 165
Self-citationElewski, B. E., Aly, R., Baldwin, S. L., González Soto, R. F., Rich, P., Weisfeld, M., Wiltz, H., Zane, L. T., & Pollak, R. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.04.010 · Cited by 164
The Interface between Fungal Biofilms and Innate Immunity
Kernien, J. F., Snarr, B. D., Sheppard, D. C., & Nett, J. E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01968 · Cited by 163
Onychomycosis: A significant medical disorder
Scher, R. K. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90061-4 · Cited by 162
Nail digital dermoscopy (Onychoscopy) in the diagnosis of onychomycosis
Piraccini, B. M., Balestri, R., Starace, M., & Rech, G. (2013) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2011.04323.x · Cited by 161
Self-citationGupta, A. K., Lynde, C. W., Jain, H. C., et al. (1997) · PubMed · Cited by 150
Self-citationAntifungal drugs during pregnancy: an updated review
Pilmis, B., Jullien, V., Sobel, J. D., Lecuit, M., Lortholary, O., & Charlier, C. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku355 · Cited by 141
Scher, R. K., Breneman, D., Rich, P., Savin, R. C., Feingold, D. S., Konnikov, N., Shupack, J. L., Pinnell, S., Levine, N., Lowe, N. J., et al. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70490-6 · Cited by 137
The epidemiology of onychomycosis: possible role of smoking and peripheral arterial disease
Gupta, A. K., Gupta, M. A., Summerbell, R. C., Cooper, E. A., Konnikov, N., Albreski, D., MacDonald, P., & Harris, K. A. (2000) · Journal of the European Academy of Dermatology and Venereology · doi:10.1046/j.1468-3083.2000.00124.x · Cited by 132
Self-citationPharmacokinetics and pharmacology of terbinafine and itraconazole
Leyden, J. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70483-9 · Cited by 129
Pierard, G. (2001) · Dermatology · doi:10.1159/000051640 · Cited by 129
Therapy of Skin, Hair and Nail Fungal Infections
Hay, R. J. (2018) · Journal of Fungi · doi:10.3390/jof4030099 · Cited by 128
Drug Permeation through the Three Layers of the Human Nail Plate
Kobayashi, Y., Miyamoto, M., Sugibayashi, K., & Morimoto, Y. (1999) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357991772448 · Cited by 126
Faergemann, J., Zehender, H., & Millérioux, L. (1994) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1994.tb01138.x · Cited by 122
Diagnosis of Dermatophytosis Using Molecular Biology
Verrier, J., & Monod, M. (2016) · Mycopathologia · doi:10.1007/s11046-016-0038-z · Cited by 121
Onychomycosis in Denmark: prevalence of fungal nail infection in general practice
Svejgaard, E. L., & Nilsson, J. (2004) · Mycoses · doi:10.1111/j.1439-0507.2004.00968.x · Cited by 120
Successful Treatment of Toenail Onychomycosis With Photodynamic Therapy
Watanabe, D. (2008) · Archives of Dermatology · doi:10.1001/archdermatol.2007.17 · Cited by 113
Gupta, A. K., & Shear, N. H. (1997) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(97)70076-8 · Cited by 108
Self-citationKobayashi, Y., Komatsu, T., Sumi, M., et al. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2003.11.008 · Cited by 104
The role of biofilms in onychomycosis
Gupta, A., Daigle, D., & Carviel, J. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.01.008 · Cited by 104
Self-citationGupta, A., Gupta, G., Jain, H. C., Lynde, C. W., Foley, K. A., Daigle, D., Cooper, E. A., & Summerbell, R. C. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13677 · Cited by 103
Self-citationPrevalence and Disease Burden of Hyperhidrosis in the Adult Population
Augustin, M., Radtke, M. A., Herberger, K., Kornek, T., Heigel, H., & Schaefer, I. (2013) · Dermatology · doi:10.1159/000351292 · Cited by 101
Haria, M., & Bryson, H. M. (1995) · Drugs · doi:10.2165/00003495-199549010-00008 · Cited by 98
Hepatic injury associated with itraconazole
Lavrijsen, A. P. M., Balmus, K. J., Nugteren‐Huying, W. M., Roldaan, A. C., Wout, J. W. V., & Stricker, B. H. C. (1992) · The Lancet · doi:10.1016/0140-6736(92)90527-a · Cited by 95
Velasquez-Agudelo, V., & Cardona‐Arias, J. A. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2258-3 · Cited by 94
Pharmacokinetics of Antifungal Agents in Onychomycoses
le Debruyne, D., & Coquerel, A. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140060-00005 · Cited by 91
The prevalence of onychomycosis in psoriatic patients: a systematic review
Klaassen, K. M. G., Dulak, M. G., van de Kerkhof, P. C. M., & Pasch, M. C. (2013) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12239 · Cited by 89
New therapeutic options for onychomycosis
Gupta, A. K., & Simpson, F. C. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.681779 · Cited by 87
Self-citationTreatment of dermatophytosis in elderly, children, and pregnant women
Dogra, S., Kaul, S., & Yadav, S. (2017) · Indian Dermatology Online Journal · doi:10.4103/idoj.idoj_169_17 · Cited by 84
Watanabe, S., Tsubouchi, I., & Okubo, A. (2018) · The Journal of Dermatology · doi:10.1111/1346-8138.14607 · Cited by 82
Antifungal Pulse Therapy for Onychomycosis
Doncker, P. D. (1996) · Archives of Dermatology · doi:10.1001/archderm.1996.03890250044008 · Cited by 76
Gupta, A. K., Konnikov, N., & Lynde, C. W. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.110874 · Cited by 75
Self-citationA Risk-Benefit Assessment of the Newer Oral Antifungal Agents Used to Treat Onychomycosis
Gupta, A. K., & Shear, N. H. (2000) · Drug Safety · doi:10.2165/00002018-200022010-00004 · Cited by 75
Self-citationSpotlight on tavaborole for the treatment of onychomycosis
Finch, J. J., & Jinna, S. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s81944 · Cited by 73
Gupta, A. K., Leonardi, C. T., Stoltz, R., Pierce, P., Conetta, B., & the Ravuconazole onychomycosis group (2005) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2005.01212.x · Cited by 71
Self-citationFungal Biofilms: Update on Resistance
Borghi, E., Borgo, F., & Morace, G. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_7 · Cited by 70
Gupta, A. K. (2000) · Drugs & Aging · doi:10.2165/00002512-200016060-00002 · Cited by 69
Self-citationPharmacokinetic Optimisation of Oral Antifungal Therapy
Schäfer-Korting, M. (1993) · Clinical Pharmacokinetics · doi:10.2165/00003088-199325040-00006 · Cited by 67
Elewski, B. E., Pollak, R. A., Ashton, S., Rich, P. A., Schlessinger, J., & Tavakkol, A. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10660.x · Cited by 65
DNA repair, immunosuppression, and skin cancer.
Gupta, A. K., & Lynch, L. E. (2004) · PubMed · Cited by 65
Self-citationEvidence for biofilms in onychomycosis
Gupta, A., & Foley, K. A. (2019) · Giornale Italiano di Dermatologia e Venereologia · doi:10.23736/s0392-0488.18.06001-7 · Cited by 65
Self-citationEuropean Handbook of Dermatological Treatments
D’Erme, A. M., Dessinioti, C., Lotti, T., & Katsambas, A. (2015) · Springer eBooks · doi:10.1007/978-3-662-45139-7 · Cited by 63
Bérard, A., Sheehy, O., Zhao, J., Gorgui, J., Bernatsky, S., de Moura, C. S., & Abrahamowicz, M. (2019) · Canadian Medical Association Journal · doi:10.1503/cmaj.180963 · Cited by 63
Gupta, A. K., & Simpson, F. C. (2013) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2013.06.009 · Cited by 63
Self-citationTopical and device-based treatments for fungal infections of the toenails
Foley, K. A., Gupta, A., Versteeg, S. G., Mays, R. R., Villanueva, E., & John, D. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012093.pub2 · Cited by 62
Self-citationRecent advances in therapies for onychomycosis and its management
Gupta, A. K., & Stec, N. (2019) · F1000Research · doi:10.12688/f1000research.18646.1 · Cited by 60
Self-citationGhannoum, M. A., Isham, N. C., Herbert, J., Henry, W., & Yurdakul, S. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00083-11 · Cited by 58
Mehlig, L., Garve, C., Ritschel, A., Zeiler, A., Brabetz, W., Weber, C., & Bauer, A. (2013) · Mycoses · doi:10.1111/myc.12097 · Cited by 58
Pharmacokinetics of Fluconazole in Normal Volunteers
Ripa, S., Ferrante, L., & Prenna, M. (2009) · Chemotherapy · doi:10.1159/000238967 · Cited by 57
Genome-wide expression profiling of the response to ciclopirox olamine in Candida albicans
Lee, R. B., Liu, T. T., Barker, K. S., Lee, R. E., & Rogers, P. D. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki105 · Cited by 57
Evaluation of nail lines: Color and shape hold clues
Lipner, S. R., & Scher, R. K. (2016) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.83a.14187 · Cited by 56
Polymerase chain reaction‐based detection of dermatophyte DNA with a fungus‐specific primer system
Bock, M., Maiwald, M., Kappe, R., Nickel, P., & Näher, H. (1994) · Mycoses · doi:10.1111/j.1439-0507.1994.tb00781.x · Cited by 55
Potential of Ravuconazole and its Prodrugs as the New OralTherapeutics for Onychomycosis
Yamaguchi, H. (2016) · Medical Mycology Journal · doi:10.3314/mmj.16-00006 · Cited by 55
Sigurgeirsson, B., van Rossem, K., Malahias, S., & Raterink, K. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.03.021 · Cited by 53
Identification of fungi species in the onychomycosis of institutionalized elderly
Vasconcellos, C., Pereira, C. D. Q. M., Souza, M. C., Pelegrini, A., de Freitas, R. S., & Takahashi, J. P. (2013) · Anais Brasileiros de Dermatologia · doi:10.1590/abd1806-4841.20131884 · Cited by 51
Gupta, A., & Nakrieko, K. (2014) · Journal of the American Podiatric Medical Association · doi:10.7547/0003-0538-104.4.330 · Cited by 51
Self-citationFungi in onychomycosis. A study by immunohistochemistry and dual flow cytometry
Arrese, J. E., Piérard-Franchimont, C., Greimers, R., & Pierard, G. (1995) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.1995.tb00305.x · Cited by 49
Hepatic Safety of Itraconazole
Gupta, A. K., Chwetzoff, E., Rosso, J. Q. D., & Baran, R. (2002) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/120347540200600302 · Cited by 48
Self-citationConfirmatory Testing Prior to Initiating Onychomycosis Therapy Is Cost-Effective
Gupta, A., Versteeg, S. G., & Shear, N. H. (2017) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/1203475417733461 · Cited by 45
Self-citationThe epidemiology of onychomycoses in Crete, Greece, between 1992 and 2001
Ioannidou, D., Maraki, S., Krasagakis, S., Tosca, A. D., & Tselentis, Y. (2006) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2006.01412.x · Cited by 44
Gupta, A., Versteeg, S. G., Shear, N. H., Piguet, V., Tosti, A., & Piraccini, B. M. (2018) · American Journal of Clinical Dermatology · doi:10.1007/s40257-018-0403-4 · Cited by 43
Self-citationEvaluation of a commercial PCR test for the diagnosis of dermatophyte nail infections
Spiliopoulou, A., Bartzavali, C., Jelastopulu, E., Anastassiou, E. D., & Christofidou, M. (2014) · Journal of Medical Microbiology · doi:10.1099/jmm.0.079962-0 · Cited by 42
Antifungal pulse therapy for onychomycosis.
Gn, S. (1996) · PubMed · Cited by 37
Ability of Hydroxypropyl Chitosan Nail Lacquer To Protect against Dermatophyte Nail Infection
Ghannoum, M. A., Long, L., Isham, N. C., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04842-14 · Cited by 36
Mechanism of Action of ME1111, a Novel Antifungal Agent for Topical Treatment of Onychomycosis
Takahata, S., Kubota, N. K., Takei‐Masuda, N., Yamada, T., Maeda, M., Alshahni, M. M., Abe, S., Tabata, Y., & Maebashi, K. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01790-15 · Cited by 32
Gupta, A., & Nakrieko, K. (2017) · Journal of the American Podiatric Medical Association · doi:10.7547/15-136 · Cited by 30
Self-citationIorizzo, M., Hartmane, I., Dērveniece, A., & Mikažāns, I. (2015) · Skin Appendage Disorders · doi:10.1159/000441569 · Cited by 26
Markinson, B. C., Ghannoum, M. A., Winter, T., Rycerz, A. M., Rock, F. L., & Gupta, A. (2018) · Journal of the American Podiatric Medical Association · doi:10.7547/16-154 · Cited by 25
Self-citationRosén, T. (2015) · PubMed · Cited by 24
Onychomycosis: Diagnosis and Therapy
Lipner, S. R., & Scher, R. K. (2015) · CRC Press eBooks · doi:10.1201/b18707-5 · Cited by 24
Karaman, B. F., Açıkalın, A., Ünal, İ., et al. (2018) · International Journal of Dermatology · doi:10.1111/ijd.14255 · Cited by 24
Recent Patents on Permeation Enhancers for Drug Delivery Through Nails
Kreutz, T., de Matos, S. P., & Koester, L. (2019) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/1872211313666191030155837 · Cited by 24
Wang, Y., & Lipner, S. R. (2019) · Journal of Dermatological Treatment · doi:10.1080/09546634.2019.1708242 · Cited by 24
A Retrospective Review of Diagnostic Testing for Onychomycosis of the Foot
Blake, N., Zhu, J., Hernandez, G., et al. (2015) · Journal of the American Podiatric Medical Association · doi:10.7547/14-063.1 · Cited by 23
Gayam, V. B. R., Khalid, M. O., Dahal, S., Garlapati, P. R., & Gill, A. S. (2018) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_330_17 · Cited by 19
Onychomycosis: current and investigational therapies.
Lipner, S. R., & Scher, R. K. (2014) · PubMed · Cited by 16
Topical and device-based treatments for fungal infections of the toenails
Gupta, A., Simpson, F. C., Daigle, D., Villanueva, E., John, D., & Foley, K. A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012093 · Cited by 14
Self-citationGupta, A., Versteeg, S. G., & Shear, N. H. (2018) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.15181 · Cited by 9
Self-citationSpotlight on tavaborole for the treatment of onychomycosis
Jinna, S., & Finch, J. J. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 6
Cited by
Development and research progress of anti-drug resistant fungal drugs
Cui, X., Wang, L., Lü, Y., & Yue, C. (2022) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2022.08.004 · Cited by 85
Metadata
- Authors
- Gupta, A. K., Stec, N., Summerbell, R. C., Shear, N. H., Piguet, V., Tosti, A., & Piraccini, B. M.
- Venue
- Journal of the European Academy of Dermatology and Venereology
- Publisher
- Wiley
- Published
- 2020-06-05
- Volume
- 34
- Issue
- 9
- Pages
- 1972-1990
- ISSN
- 0926-9959 (ISSN-L)
- 1468-3083
- OpenAlex
- W3015004082
- Cited by
- 289
- References
- 105
- FWCI
- 23.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.